4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
March 17, 2010 10:03 pm US/Eastern
Search
Dynamic quotes   
On
 | Off

4-Traders Homepage  >  Shares  >  NYSE  >  WATSON PHARM   WPI   US9426831031

Real time Streaming quotes -

WATSON PHARM (WPI)

  
Delayed Quote. Delayed NYSE - 03/17 04:02:57 pm
40.63 USD   -0.05%
03/16WATSON PHARM: Watson to Present at Barclay's 2010 Global Healthc..
03/15WATSON PHARM: Watson Receives FDA Approval for Generic Cardizem(..
03/11WATSON PHARM: FDA Approves Watson's TRELSTAR(R) 22.5 mg, the Fir..
SummaryQuotesChart AnalysisNewsFundamentalsConsensus
NewsRSS News
Latest news on WATSON PHARM
03/16Watson to Present at Barclay's 2010 Global Healthcare Conference
03/15Watson Receives FDA Approval for Generic Cardizem(R) LA
03/11FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month ..
03/10Watson Announces Actos(R) Patent Challenge Settlement
03/08Watson Confirms Filing of Generic Opana(R) ER Application
03/04Watson Announces Agreement to Acquire U.S. Rights to Columbia Laborato..
03/01Watson Signs Agreement to Divest Equity Interest in ScinoPharm
03/01Watson Licenses Population Council's Novel Contraceptive Ring
02/26Watson to Present at CLSA/Asia USA Investor's Forum
02/23Watson Reports Net Revenue of $786 Million for the Fourth Quarter 2009
02/22Watson Files FDA Application for Generic Aplenzin(TM) ER
02/02Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2..
02/01Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commer..
01/28Watson Completes Acquisition of Eden Biodesign
01/21Watson Provides Overview of Global Operations; Delivers Outlook for Co..
01/19/C O R R E C T I O N -- Watson Pharmaceuticals, Inc./
01/13Watson Announces Preliminary Financial Performance for FY 2009
01/08Watson Files FDA Application for Generic LoSeasonique(R)
01/06Watson Files FDA Application for Generic Nuvigil(R)
01/06Watson to Present at 28th Annual JPMorgan Healthcare Conference
>> News
Analyst Recommendations on WATSON PHARM
Sell
Buy Average goal : 44.50$ Nbr of analysts : 17

- No features available -

>> More recommendations
Stratégies d'investissement 
- No features available -
>> Plus de Stratégies d'investissement
Stratégies de Trading 
- No features available -
Interviews

- No interview available -

All RSS news on WATSON PHARM
- No features available -
Chart WATSON PHARM
Short term
Mid-term
Long term
Graphique historique des cours de bourse de WATSON PHARM
>> Full-screen chart
Price share WATSON PHARM (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /